DK1248630T3 - Anvendelse af et dermatologisk præparat indeholdende oligosaccharider til behandling af hudsygdomme - Google Patents

Anvendelse af et dermatologisk præparat indeholdende oligosaccharider til behandling af hudsygdomme

Info

Publication number: DK1248630T3
Authority: DK; Denmark
Prior art keywords: treatment; composition containing; skin diseases; dermatological composition; containing oligosaccharides
Prior art date: 1999-12-20

Application number

DK00990076T

Other languages

English (en)

Inventor

Gerard Martinez

Christian Francisco

Original Assignee

G Pharm Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-20

Filing date

2000-12-20

Publication date

2004-11-15

2000-12-20 Application filed by G Pharm Lab filed Critical G Pharm Lab

2004-11-15 Application granted granted Critical

2004-11-15 Publication of DK1248630T3 publication Critical patent/DK1248630T3/da

Links

239000000203 mixture Substances 0.000 title abstract 3
229920001542 oligosaccharide Polymers 0.000 title 1
150000002482 oligosaccharides Chemical class 0.000 title 1
208000017520 skin disease Diseases 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
150000004676 glycans Chemical class 0.000 abstract 2
229920001282 polysaccharide Polymers 0.000 abstract 2
239000005017 polysaccharide Substances 0.000 abstract 2
239000004475 Arginine Substances 0.000 abstract 1
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 abstract 1
MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 abstract 1
UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 abstract 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
GZCGUPFRVQAUEE-KCDKBNATSA-N aldehydo-D-galactose Chemical group OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-KCDKBNATSA-N 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
230000003266 anti-allergic effect Effects 0.000 abstract 1
230000001088 anti-asthma Effects 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1
230000001139 anti-pruritic effect Effects 0.000 abstract 1
230000002682 anti-psoriatic effect Effects 0.000 abstract 1
239000000924 antiasthmatic agent Substances 0.000 abstract 1
239000003908 antipruritic agent Substances 0.000 abstract 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
230000035515 penetration Effects 0.000 abstract 1
230000008884 pinocytosis Effects 0.000 abstract 1
239000001397 quillaja saponaria molina bark Substances 0.000 abstract 1
MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 abstract 1
229930182490 saponin Natural products 0.000 abstract 1
150000007949 saponins Chemical class 0.000 abstract 1
UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 abstract 1
125000000185 sucrose group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Dermatology (AREA)
Birds (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Mycology (AREA)
Microbiology (AREA)
Botany (AREA)
Immunology (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Hematology (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK00990076T 1999-12-20 2000-12-20 Anvendelse af et dermatologisk præparat indeholdende oligosaccharider til behandling af hudsygdomme DK1248630T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9916060A FR2802414B1 (fr)	1999-12-20	1999-12-20	Composition, notamment cosmetique ou dermatologique, contenant des oligosaccharides, son procede de preparation et un procede de traitement cosmetique
PCT/FR2000/003607 WO2001045713A1 (fr)	1999-12-20	2000-12-20	Composition, notamment cosmetique ou dermatologique, contenant des oligosaccharides, son procede de preparation et un procede de ttraitement cosmetique

Publications (1)

Publication Number	Publication Date
DK1248630T3 true DK1248630T3 (da)	2004-11-15

Family

ID=9553473

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00990076T DK1248630T3 (da)	1999-12-20	2000-12-20	Anvendelse af et dermatologisk præparat indeholdende oligosaccharider til behandling af hudsygdomme

Country Status (13)

Country	Link
US (1)	US6946121B2 (da)
EP (2)	EP1464330B1 (da)
JP (1)	JP2003518066A (da)
AT (2)	ATE270892T1 (da)
AU (1)	AU778953B2 (da)
CA (1)	CA2395121C (da)
DE (2)	DE60034898T2 (da)
DK (1)	DK1248630T3 (da)
ES (1)	ES2222939T3 (da)
FR (1)	FR2802414B1 (da)
PT (1)	PT1248630E (da)
TR (1)	TR200401935T4 (da)
WO (1)	WO2001045713A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7629384B2 (en)	1997-09-17	2009-12-08	Strategic Science & Technologies, Llc	Topical delivery of L-arginine to cause beneficial effects
US7914814B2 (en)	1997-09-17	2011-03-29	Strategic Science & Technologies, Llc	Topical delivery of arginine of cause beneficial effects
JP4178829B2 (ja)	2002-05-02	2008-11-12	株式会社Ｊ−オイルミルズ	抗アレルギー性組成物
WO2003101464A1 (fr) *	2002-05-31	2003-12-11	Amano Enzyme Inc.	Anti-inflammatoire, agent de lutte contre des affections allergiques, et aliment fonctionnel
EP1529532A1 (en) *	2003-11-07	2005-05-11	Kabushiki Kaisha Honen Corporation	Antiallergic composition comprising stachyose
CA2556967A1 (en) *	2004-02-23	2005-09-09	Strategic Science & Technologies, Llc	Topical delivery of a nitric oxide donor to improve body and skin appearance
FR2868703B1 (fr) *	2004-04-08	2008-06-13	Expanscience Sa Lab	Extrait total de lupin constitue d'un extrait de sucres de lupin et d'un extrait peptidique de lupin, procede d'obtention et utilisation
EP1737441A4 (en) *	2004-04-19	2009-05-20	Strategic Science & Technologi	ADVANTAGEOUS EFFECTS OF REINFORCING LOCAL FLOW
US9226909B2 (en)	2004-04-19	2016-01-05	Strategic Science & Technologies, Llc	Beneficial effects of increasing local blood flow
EP2417978A1 (en) *	2004-04-19	2012-02-15	Strategic Science & Technologies, LLC	Beneficial effects of increasing local blood flow
US20090215717A1 (en) *	2004-08-05	2009-08-27	Ivax Drug Research Institute Ltd.	Sulfated oligosaccharides
FR2917971B1 (fr)	2007-06-28	2009-10-23	Engelhard Lyon Soc Par Actions	Composition amincissante
US8153611B2 (en) *	2007-06-28	2012-04-10	Basf Beauty Care Solutions France S.A.S.	Use of sulfated oligosaccharides as slimming cosmetic ingredients
US11684624B2 (en)	2009-06-24	2023-06-27	Strategic Science & Technologies, Llc	Treatment of erectile dysfunction and other indications
EP2445493A1 (en)	2009-06-24	2012-05-02	Strategic Science & Technologies, LLC	Topical composition containing naproxen
NZ597542A (en)	2009-06-24	2014-01-31	Strategic Science & Tech Llc	Topical composition containing ibuprofen
GB0915315D0 (en)	2009-09-03	2009-10-07	Univ Manchester	Use of non-digestible oligosaccharides
US9289495B2 (en)	2010-12-29	2016-03-22	Strategic Science & Technologies, Llc	Systems and methods for treatment of allergies and other indications
EP3721893A1 (en)	2010-12-29	2020-10-14	Strategic Science & Technologies, LLC	Treatment of erectile dysfunction
TWI725008B (zh) *	2015-01-28	2021-04-21	瑞采生技有限公司	用於增強ＰＰＡＲγ表現及核轉位之化合物及其醫療用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5777620A (en) *	1980-11-04	1982-05-15	Atsushi Watanabe	Carcinostatic agent
JPS59176203A (ja) *	1983-03-28	1984-10-05	Kanebo Ltd	皮膚化粧料
JPS62412A (ja) *	1985-06-25	1987-01-06	Shiseido Co Ltd	化粧料
JPS62277323A (ja) *	1986-02-19	1987-12-02	Sankyo Co Ltd	フマル酸ケトチフエン含有点眼液の製法
US6294520B1 (en) *	1989-03-27	2001-09-25	Albert T. Naito	Material for passage through the blood-brain barrier
JPH02286078A (ja) *	1989-04-26	1990-11-26	Ajinomoto Co Inc	ビフィズス菌増殖促進組成物及びその製造法
JP3665852B2 (ja) *	1998-03-10	2005-06-29	日本甜菜製糖株式会社	抗アトピー性皮膚炎組成物
JP4099267B2 (ja) *	1998-08-07	2008-06-11	株式会社紀文フードケミファ	乳化剤および乳化組成物

1999
- 1999-12-20 FR FR9916060A patent/FR2802414B1/fr not_active Expired - Fee Related
2000
- 2000-12-20 AT AT00990076T patent/ATE270892T1/de not_active IP Right Cessation
- 2000-12-20 ES ES00990076T patent/ES2222939T3/es not_active Expired - Lifetime
- 2000-12-20 US US10/168,063 patent/US6946121B2/en not_active Expired - Fee Related
- 2000-12-20 JP JP2001546652A patent/JP2003518066A/ja active Pending
- 2000-12-20 TR TR2004/01935T patent/TR200401935T4/xx unknown
- 2000-12-20 EP EP04075969A patent/EP1464330B1/fr not_active Expired - Lifetime
- 2000-12-20 AU AU26880/01A patent/AU778953B2/en not_active Ceased
- 2000-12-20 AT AT04075969T patent/ATE362386T1/de not_active IP Right Cessation
- 2000-12-20 DE DE60034898T patent/DE60034898T2/de not_active Expired - Fee Related
- 2000-12-20 DK DK00990076T patent/DK1248630T3/da active
- 2000-12-20 PT PT00990076T patent/PT1248630E/pt unknown
- 2000-12-20 EP EP00990076A patent/EP1248630B9/fr not_active Expired - Lifetime
- 2000-12-20 WO PCT/FR2000/003607 patent/WO2001045713A1/fr active IP Right Grant
- 2000-12-20 DE DE60012230T patent/DE60012230T2/de not_active Expired - Fee Related
- 2000-12-20 CA CA2395121A patent/CA2395121C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ATE362386T1 (de)	2007-06-15
PT1248630E (pt)	2004-12-31
JP2003518066A (ja)	2003-06-03
DE60012230T2 (de)	2005-08-04
EP1248630B1 (fr)	2004-07-14
EP1248630A1 (fr)	2002-10-16
DE60012230D1 (de)	2004-08-19
EP1248630B9 (fr)	2005-01-05
CA2395121C (fr)	2010-03-16
FR2802414B1 (fr)	2003-06-27
DE60034898T2 (de)	2008-02-07
AU2688001A (en)	2001-07-03
US6946121B2 (en)	2005-09-20
EP1464330A1 (fr)	2004-10-06
CA2395121A1 (fr)	2001-06-28
AU778953B2 (en)	2004-12-23
TR200401935T4 (tr)	2004-10-21
EP1464330B1 (fr)	2007-05-16
DE60034898D1 (de)	2007-06-28
ES2222939T3 (es)	2005-02-16
US20030045505A1 (en)	2003-03-06
FR2802414A1 (fr)	2001-06-22
ATE270892T1 (de)	2004-07-15
WO2001045713A1 (fr)	2001-06-28

Publication	Publication Date	Title
DK1248630T3 (da)	2004-11-15	Anvendelse af et dermatologisk præparat indeholdende oligosaccharider til behandling af hudsygdomme
DE3686645T2 (de)	1993-04-15	Pharmazeutische zusammensetzungen zur verbesserung von wundheilung.
BR0011640A (pt)	2002-05-14	ácidos aldÈnicos de oligossacarìdeo e seu uso tópico
BRPI9909908B8 (pt)	2021-05-25	conjugados de ácido graxo de sal ou ácido biliar, composição farmacêutica compreendendo os mesmos e seus usos
JPS6322517A (ja)	1988-01-30	皮膚病に対するアリ−ルオキシカルボン酸誘導体の用途
EP1493431A3 (de)	2005-03-23	Verwendung eines Extrakts aus Bauhinia zur Herstellung kosmetischer und pharmazeutischer Zubereitungen
JPH11246333A (ja)	1999-09-14	収斂用化粧料におけるケイ皮酸またはその誘導体の用途
ATE221376T1 (de)	2002-08-15	Verwendung von nmifa als entzündungshemmer in oberflächlichem saugetier-gewebe
KR100273389B1 (ko)	2001-02-01	조직노화의 예방과 치료에의 올리고당류의 사용
DE602005002734D1 (de)	2007-11-15	Derivate von genkwanin und sakuranetin, deren kosmetische und therapeutische verwendung, und verfahren zu deren herstellung
Bhattacherjee et al.	1983	A comparison of the ocular anti-inflammatory activity of steroidal and nonsteroidal compounds in the rat.
DE69133077D1 (de)	2002-08-29	Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
BRPI0415623B8 (pt)	2021-05-25	utilização de um monômero de ramnose, bem como métodos de tratamento cosmético
KR20040106368A (ko)	2004-12-17	세포 증식제
Majumder et al.	2014	Efficacy of Haemocoagulase as a topical Haemostatic agent after minor Oral surgical procedures—a prospective study
US6783774B1 (en)	2004-08-31	Substance that stop any kind of bleeding within one second for medical, surgical, postsurgical and dental uses
ATE374060T1 (de)	2007-10-15	Kosmetische verwendung von neuen abschuppenden mitteln
Iacoviello et al.	1992	Different response of vascular fibrinolysis to adrenergic stimulation in young and aged rats
Franke et al.	1944	Effects of sublethal doses of a polysaccharide from Serratia marcescens (Bacillus prodigiosus) on the electrocardiogram, blood ascorbic acid, and nonprotein nitrogen of the dog
HASHIMOTO et al.	1984	Clinical Experience with ZA-552 (Avitene®) in the Oral Surgery
TH5628A (th)	1989-02-01	ส่วนประกอบสารรักษาผิว
RU94038468A (ru)	1996-09-20	Способ в.ф.можаровского комплексного этиологического лечения псориаза противовирусным и противомикробными препаратами "ликвацид", "тринол", "трисолид" и "тротицид"
BR9805072A (pt)	2000-06-06	Composição farmacêutica imunoestimulante e seu método de aplicação